Atypical Ductal Hyperplasia

Atypical ductal hyperplasia, often shortened to ADH, is a benign finding in the breast that is best understood by breaking down its name. Hyperplasia means an overgrowth of cells, ductal tells you these cells line a milk duct, and atypical means the cells look a little unusual under the microscope, though not enough to be called cancer. Put together, it describes an accumulation of slightly abnormal cells inside a breast duct.

ADH is most often discovered not because it causes a lump you can feel, but because a mammogram picked up tiny calcifications or another subtle change, prompting a biopsy. When the tissue is examined, the pathologist recognizes the atypical pattern. It is important to hold onto the key fact here: ADH is not breast cancer. It is a benign condition, and on its own it does not threaten your health in the way a malignant tumor would.

What makes ADH worth taking seriously is what it signals about the future. Women who have had ADH carry a somewhat higher risk of developing breast cancer down the line, in either breast, compared to women who have not. For that reason, a diagnosis often leads to closer follow-up, more attentive screening, and sometimes a conversation about steps that can lower risk. It is a marker that invites watchfulness rather than alarm.

Atypical ductal hyperplasia sits in an in-between space that can be confusing: it is not cancer, yet it is not nothing either. Understanding it as a risk marker rather than a disease helps make sense of why a benign finding might still change how closely your breasts are watched, and why your care team may suggest more frequent imaging or discuss prevention.

Knowing what ADH means can also turn an unsettling biopsy result into something you can engage with thoughtfully. Rather than living with vague worry, you can understand that this finding has given you and your doctors useful information, an early heads-up that lets you be proactive about screening and risk-reduction long before any problem might arise.